Back to Search
Start Over
Anti-IL-5 (mepolizumab) therapy does not alter IL-5 receptor alpha levels in patients with eosinophilic esophagitis.
- Source :
-
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2009 Jan; Vol. 123 (1), pp. 269; author reply 269-70. Date of Electronic Publication: 2008 Oct 25. - Publication Year :
- 2009
- Subjects :
- Adolescent
Adult
Antibodies, Monoclonal, Humanized
Cytokines biosynthesis
Enzyme-Linked Immunosorbent Assay
Eosinophilia blood
Female
Flow Cytometry
Fluorescent Antibody Technique
Humans
Interleukin-5 antagonists & inhibitors
Male
Middle Aged
Receptors, Interleukin-5 blood
T-Lymphocyte Subsets drug effects
T-Lymphocytes drug effects
Antibodies, Monoclonal therapeutic use
Eosinophilia drug therapy
Eosinophils drug effects
Interleukin-5 blood
Receptors, Interleukin-5 drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1097-6825
- Volume :
- 123
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- The Journal of allergy and clinical immunology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 18951621
- Full Text :
- https://doi.org/10.1016/j.jaci.2008.09.031